ACCENTIA BIOPHARMACEUTICALS INC·4

Dec 21, 4:40 PM ET

ACCENTIA BIOPHARMACEUTICALS INC 4

4 · ACCENTIA BIOPHARMACEUTICALS INC · Filed Dec 21, 2010

Insider Transaction Report

Form 4
Period: 2010-12-17
Pearce Alan M
DirectorChief Financial Officer
Transactions
  • Other

    Common Stock

    2010-12-17+206,8961,194,403 total
Footnotes (1)
  • [F1]Represents acquisition of common stock of Accentia Biopharmaceuticals, Inc. by reporting person from a third-party in a private transaction.

Documents

1 file
  • 4
    rrd295112.xmlPrimary